000 | 01642 a2200433 4500 | ||
---|---|---|---|
005 | 20250514161412.0 | ||
264 | 0 | _c20031201 | |
008 | 200312s 0 0 eng d | ||
022 | _a0077-8923 | ||
024 | 7 |
_a10.1196/annals.1254.005 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPlomp, J J | |
245 | 0 | 0 |
_aTransmitter release deficits at the neuromuscular synapse of mice with mutations in the Cav2.1 (alpha1A) subunit of the P/Q-type Ca2+ channel. _h[electronic resource] |
260 |
_bAnnals of the New York Academy of Sciences _cSep 2003 |
||
300 |
_a29-32 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAcetylcholine _xanalysis |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCalcium Channel Blockers _xpharmacology |
650 | 0 | 4 |
_aCalcium Channels, N-Type _xgenetics |
650 | 0 | 4 |
_aDiaphragm _xdrug effects |
650 | 0 | 4 | _aElectric Stimulation |
650 | 0 | 4 | _aElectrophysiology |
650 | 0 | 4 |
_aExcitatory Postsynaptic Potentials _xdrug effects |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Neurologic Mutants |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 |
_aNeuromuscular Junction _xdrug effects |
650 | 0 | 4 |
_aNeurotransmitter Agents _xdeficiency |
650 | 0 | 4 | _aSpecies Specificity |
650 | 0 | 4 |
_aomega-Agatoxin IVA _xpharmacology |
700 | 1 | _avan den Maagdenberg, A M | |
700 | 1 | _aFerrari, M D | |
700 | 1 | _aFrants, R R | |
700 | 1 | _aMolenaar, P C | |
773 | 0 |
_tAnnals of the New York Academy of Sciences _gvol. 998 _gp. 29-32 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1196/annals.1254.005 _zAvailable from publisher's website |
999 |
_c14331056 _d14331056 |